Bedaya Hospital
10
3
3
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger
Role: lead
Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger
Role: lead
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders
Role: lead
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
Role: lead
Ultrasound Guidance of Office Hysteroscopy in Patients With History of Failure of Office Hysteroscopy Due to Cervical Stenosis.
Role: collaborator
Bladder Distension for Pain Relief in Patients With Excessive Anteflexion of Uterus Undergoing Office Hysteroscopy
Role: collaborator
Bladder Distension for Pain Relief in Nullliparous Patients Undergoing Diagnostic Office Hysteroscopy
Role: collaborator
Full Bladder IUD Insertion Without Vulsellum Under Ultrasound Guidance
Role: collaborator
Hysteroscopic Guided Versus Ultrasound Guided Extraction of Retained IUD
Role: collaborator
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger
Role: lead
All 10 trials loaded